FDA.reportPublic FDA data

Ceftazidime

Product NDC
25021-129
11-digit product format
250210129
Labeler code
25021
Product ID
25021-129_c6b97c07-4742-4c33-8266-a154bd634da5
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ceftazidime
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Labeler
Sagent Pharmaceuticals
Application
ANDA062640
Marketing category
ANDA
Marketing start
2008-05-15
Substance
CEFTAZIDIME
Active strength
6 g/30mL
Pharmacologic classes
Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Ceftazidime
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CEFTAZIDIME6 g/30mL

Harmonized Identifiers#

Field, Values table
FieldValues
Unii9M416Z9QNR
Rxcui242800

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
fb7d24f2-fcd1-4dc6-b9d0-b1f65bfffab5Product name120150409

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
25021-129-99Ceftazidime6 in 1 CARTONINJECTION, POWDER, FOR SOLUTION69
25021-129-99Ceftazidime30 mL in 1 BOTTLEINJECTION, POWDER, FOR SOLUTION309

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
25021-129-69EA - Each25021-129a077df90-36d2-41d2-a12e-5ac3faa51ef012015-07-20
25021-129-99EA - Each25021-12912d09ca1-c5f9-49bd-8c55-e4ce1008101312012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ceftazidimeACTIVE INGREDIENT9M416Z9QNRCEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS]4
CEFTAZIDIME ANHYDROUSACTIVE MOIETYDZR1ENT301CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS]4
sodium carbonateINACTIVE INGREDIENT45P3261C7TCEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS]4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
25021-129CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS]9Current NDC, Legacy NDC, 2 package rows20240105_aec64360-8452-4987-a366-a5a4f8762ab6.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
242800cefTAZidime 200 MG/ML Injectable SolutionPSNaec64360-8452-4987-a366-a5a4f8762ab69
242800ceftazidime 200 MG/ML Injectable SolutionSCDaec64360-8452-4987-a366-a5a4f8762ab69
242800ceftazidime 200 MG/ML Concentrate for Injectable SolutionSYaec64360-8452-4987-a366-a5a4f8762ab69
242800ceftazidime 6 GM per 30 ML Injectable SolutionSYaec64360-8452-4987-a366-a5a4f8762ab69

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
25021-129-69250210129696 BOTTLE in 1 CARTON (25021-129-69) > 30 mL in 1 BOTTLE6 bottle2015-07-010000-00-00NoNoCurrent
25021-129-99250210129996 BOTTLE in 1 CARTON (25021-129-99) / 30 mL in 1 BOTTLE6 bottle2008-05-150000-00-00NoNoCurrent